COMMON

Nikola Reminds Romeo Power Stockholders to Tender Shares in Exchange Offer Before Deadline on September 26, 2022

Retrieved on: 
Tuesday, September 20, 2022
Transfer, Registration statement, Eastern Time Zone, Schedule, Corporation, NYSE, Risk, Personal Information Agent, U.S. Securities and Exchange Commission, Contract, Acquisition, 8-K, Forward-looking statement, Commerce, Letter, Investor relations, Solution, Transport, Tender, Telephone, California County Routes in zone S, Form, ARE, SEC, Multimedia, Communication, Nikola Corporation, Money transmitter, COMMON, Register, Holding company, Security (finance), Exchange

Nikola and Romeo jointly announced that the companies entered into a definitive agreement for this all-stock transaction on August 1, 2022.

Key Points: 
  • Nikola and Romeo jointly announced that the companies entered into a definitive agreement for this all-stock transaction on August 1, 2022.
  • Nikola is urging Romeo stockholders to tender their shares before the deadline of midnight, Eastern Time, at the end of September 26, 2022.
  • If less than a majority of the outstanding shares of Romeo's common stock are tendered, the Offer cannot be completed.
  • Alliance Advisors is acting as Information Agent for the Offer and Continental Stock Transfer & Trust Company is acting as Exchange Agent in the Offer.

KRBP Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of October 4, 2022 Deadline in Securities Fraud Class Action Lawsuit

Retrieved on: 
Monday, September 19, 2022
Time, FDA, COPY, IND, CLASS, Immunotherapy, AND, LLP, IPO, Artificial intelligence, Fraud, Investigational New Drug, Insurance, NASDAQ, District court, GLOBE, Lead, COMMON, Private investigator, Pharmaceutical industry, Architecture, Kirom Bukhoroi

Kessler Topaz Meltzer & Check, LLP encourages Kiromic investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Kiromic investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .

The Rosen Law Firm, P.A. Announces Proposed Securities Class Action Settlement on Behalf of Purchasers of Intrusion, Inc. common stock – INTZ

Retrieved on: 
Monday, September 19, 2022
BOTH, Settlement, Claim, Igneous intrusion, Suite, Fax, Inc., Judgement, Hearing, AND, Prejudice, TEL, Ownership, Leading Counsel, Court, NASDAQ, Agreement, Security (finance), District court, GLOBE, Notice, ALL, Texas State Highway 289, COMMON, Online gambling, Insurance, Media

The Court reserves the right to hold the Settlement Hearing telephonically or by other virtual means.

Key Points: 
  • The Court reserves the right to hold the Settlement Hearing telephonically or by other virtual means.
  • You can also download copies of the Notice and submit your Proof of Claim and Release Form online at www.strategicclaims.net/Intrusion/ .
  • Unless you submit a written exclusion request, you will be bound by any judgment rendered in the Action whether or not you make a claim.
  • All members of the Settlement Class who do not timely request exclusion from the Settlement Class will be bound by any judgment entered in the Action pursuant to the Stipulation.

Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc.

Retrieved on: 
Monday, September 12, 2022
Time, FDA, COPY, IND, CLASS, Immunotherapy, AND, LLP, IPO, Artificial intelligence, Fraud, Investigational New Drug, Insurance, NASDAQ, District court, GLOBE, Lead, COMMON, Private investigator, Pharmaceutical industry, Architecture, Kirom Bukhoroi

As a result of Kiromics materially misleading statements and omissions to the public, Kiromic investors have suffered significant losses.

Key Points: 
  • As a result of Kiromics materially misleading statements and omissions to the public, Kiromic investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Kiromic investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

KRBP EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit filed against Kiromic BioPharma, Inc.

Retrieved on: 
Saturday, September 3, 2022
Investigational New Drug, District court, Artificial intelligence, IND, Insurance, NASDAQ, LLP, Time, IPO, AND, Lead, GLOBE, FDA, Immunotherapy, Fraud, COPY, CLASS, COMMON, Private investigator, Pharmaceutical industry, Architecture, Kirom Bukhoroi

The action charges Kiromic with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.

Key Points: 
  • The action charges Kiromic with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Kiromic investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

Nikola Commences Exchange Offer to Acquire Romeo Power

Retrieved on: 
Tuesday, August 30, 2022
Transfer, Telephone, Corporation, NYSE, Siesta Key (TV series), Register, Letter, Solution, Nikola Corporation, 8-K, Personal Information Agent, Investor relations, Forward-looking statement, SEC, ARE, Multimedia, U.S. Securities and Exchange Commission, Tender, Commerce, Schedule TO, Form, California County Routes in zone S, Schedule, Eastern Time Zone, Risk, Money transmitter, COMMON, Alliance, Industry, Acquisition, Transport, Contract, Registration statement, Security (finance), Exchange

Upon the successful completion of the Offer, a newly formed subsidiary of Nikola will be merged into Romeo, and any remaining shares of Romeo common stock that were not tendered in the exchange offer will be canceled and converted into the right to receive the same consideration as provided for in the exchange offer.

Key Points: 
  • Upon the successful completion of the Offer, a newly formed subsidiary of Nikola will be merged into Romeo, and any remaining shares of Romeo common stock that were not tendered in the exchange offer will be canceled and converted into the right to receive the same consideration as provided for in the exchange offer.
  • Nikola has filed with the U.S. Securities and Exchange Commission (the "SEC") a tender offer statement on Schedule TO, which includes a summary of the terms of the Offer.
  • This document is not a substitute for the Registration Statement, the Tender Offer Statement, the Solicitation/Recommendation Statement or any other document that Nikola or Romeo may file with the SEC related to the transaction (collectively, the "Exchange Offer Materials").THE EXCHANGE OFFER MATERIALS CONTAIN IMPORTANT INFORMATION.
  • In addition to the Exchange Offer Materials, Nikola and Romeo file annual, quarterly and current reports and other information with the SEC.

Robbins Geller Rudman & Dowd LLP and Motley Rice LLC Announce Class Action Settlement Involving Purchasers of Twitter, Inc. Common Stock

Retrieved on: 
Tuesday, August 30, 2022
Federal Rules of Civil Procedure, Motion, Federal building, TWITTER, District court, Good, Class representative, Judgement, Client First Settlement Funding, Twitter, Hearing, Agreement, Defendant, AND, YOU, Allocation, Court, Settlement, PO, OR, Settlement (litigation), Lawsuit, SET, Inc., Courthouse, THE, COMMON, CLASS, Dismissal, Clay Street Bridge, Tobacco, Insurance, Claim, Notice

IF YOU PURCHASED OR ACQUIRED TWITTER, INC. ("TWITTER") PUBLICLY TRADED COMMON STOCK FROM FEBRUARY 6, 2015 THROUGH JULY 28, 2015, INCLUSIVE, AND WERE DAMAGED THEREBY (THE "CLASS"), YOU COULD RECEIVE A PAYMENT FROM A CLASS ACTION SETTLEMENT.

Key Points: 
  • IF YOU PURCHASED OR ACQUIRED TWITTER, INC. ("TWITTER") PUBLICLY TRADED COMMON STOCK FROM FEBRUARY 6, 2015 THROUGH JULY 28, 2015, INCLUSIVE, AND WERE DAMAGED THEREBY (THE "CLASS"), YOU COULD RECEIVE A PAYMENT FROM A CLASS ACTION SETTLEMENT.
  • CERTAIN PERSONS ARE EXCLUDED FROM THE DEFINITION OF THE CLASS AS SET FORTH IN THE STIPULATION OF SETTLEMENT.
  • YOUR RIGHTS MAY BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
  • If you have any questions about the Settlement, or your eligibility to participate in the Settlement, you may contact Class Counsel:

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Kiromic BioPharma, Inc. of Securities Class Action Lawsuit and Urges Investors with Significant Losses to Contact the Firm

Retrieved on: 
Friday, August 26, 2022
Investigational New Drug, District court, IND, Artificial intelligence, Insurance, NASDAQ, LLP, Time, IPO, AND, Lead, GLOBE, FDA, Immunotherapy, Fraud, COPY, CLASS, COMMON, Private investigator, Pharmaceutical industry, Architecture, Kirom Bukhoroi

As a result of Kiromics materially misleading statements and omissions to the public, Kiromic investors have suffered significant losses.

Key Points: 
  • As a result of Kiromics materially misleading statements and omissions to the public, Kiromic investors have suffered significant losses.
  • We are proud to have recovered billions of dollars for our clients and the classes of shareholders we represent.
  • Kessler Topaz Meltzer & Check, LLP encourages Kiromic investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.

Scott+Scott Attorneys at Law LLP, Hedin Hall LLP, and Hagens Berman Sobol Shapiro LLP Announce Proposed Class Action Settlement on Behalf of All Persons who Purchased or Otherwise Acquired Pivotal Software, Inc. Common Stock Issued in Connection with Pivo

Retrieved on: 
Friday, August 19, 2022
Prospectus, Stipulation, Class, U.S. Securities and Exchange Commission, Time, Initial public offering, Pivotal Software, ALL, SEC, Settlement, County, THE, Plaintiff, Person, Dell, Counsel, Superior court, Judgement, Client First Settlement Funding, Exclusion, Claim, Notice, SOFTWARE, Dell Technologies, California superior courts, IPO, Hearing, Court, THIS, Database, CLASS, COMMON, Class Action, Offering, Security (finance), Insurance, Authorization, Pivotal

YOU ARE HEREBY NOTIFIED that a hearing will be held on DECEMBER 1, 2022, at 2:00 p.m. before the Honorable Andrew Y.S.

Key Points: 
  • YOU ARE HEREBY NOTIFIED that a hearing will be held on DECEMBER 1, 2022, at 2:00 p.m. before the Honorable Andrew Y.S.
  • IF YOU PURCHASED OR ACQUIRED PIVOTAL COMMON STOCK PURSUANT OR TRACEABLE TO THE OFFERING DOCUMENTS ISSUED IN CONNECTION WITH PIVOTAL'S IPO, YOUR RIGHTS WILL BE AFFECTED BY THE SETTLEMENT OF THIS ACTION.
  • If you want to be represented by your own lawyer, you may hire one at your own expense.
  • For Authorized Claimants whose checks are returned as undeliverable, the Claims Administrator will endeavor to locate new addresses for the recipient.

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc. (KRBP) and Encourages Investors with Significant Losses to Contact the Firm

Retrieved on: 
Friday, August 19, 2022
Class Action Lawsuit, Professional Services, Legal, Investigational New Drug, Artificial intelligence, IND, Insurance, NASDAQ, LLP, Time, IPO, AND, Lead, Immunotherapy, FDA, Fraud, COPY, CLASS, COMMON, Private investigator, Pharmaceutical industry, Kirom Bukhoroi

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Kiromic BioPharma, Inc. (Kiromic) ( NASDAQ: KRBP ).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Kiromic BioPharma, Inc. (Kiromic) ( NASDAQ: KRBP ).
  • As a result of Kiromics materially misleading statements and omissions to the public, Kiromic investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Kiromic investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.